Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ibuprofen + caffeine
- Development stage
- Phase 3
- Lead developer
- Sanofi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ibuprofen + caffeine is a fixed-dose combination of two active ingredients used primarily for the treatment of acute pain, such as postoperative pain and tension-type headaches. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Caffeine, a methylxanthine stimulant, enhances the analgesic effect of ibuprofen by antagonizing adenosine receptors in the brain and may also aid in faster absorption of ibuprofen. Clinical studies have shown that this combination provides superior pain relief compared to either agent alone, with faster onset and greater efficacy for moderate to severe acute pain[1][2][3][4][5].
- Brand names
- Thomapyrin Tension DuoSpalt ForteAdvil Caffeine
- Other names
- Ibuprofen/Caffeine FDCIbuprofen/Caffeine 400mg/100mgFixed-dose combination of ibuprofen and caffeine
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Ibuprofen + caffeine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ibuprofen + caffeine.